We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+11.73%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$194M
AUM Growth
-$78M
(-29%)
Cap. Flow
-$87.1M
Cap. Flow
% of AUM
-44.94%
Top 10 Holdings %
Top 10 Hldgs %
40.18%
Holding
105
New
33
Increased
15
Reduced
10
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$10.1M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$4.72M |
| 3 |
CONMED
CNMD
|
+$4.58M |
| 4 |
Insulet
PODD
|
+$4.57M |
| 5 |
Cigna
CI
|
+$4.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$9.42M |
| 2 |
ResMed
RMD
|
+$8.01M |
| 3 |
Edwards Lifesciences
EW
|
+$4.71M |
| 4 |
AGN
Allergan Inc
AGN
|
+$4.52M |
| 5 |
EXAS
Exact Sciences
EXAS
|
+$4.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 54.96% |
| 2 | Financials | 0% |
| 3 | Utilities | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
CALL
Baxter International
BAX
$14.7B
| $17.1M | 8.84% |
+460,250
| New | +$17.5M |
|
|
2
Baxter International
BAX
$14.7B
| $9.93M | 5.13% |
+266,945
| New | +$10.1M |
|
3
Boston Scientific
BSX
$71.1B
| $9.32M | 4.81% |
525,000
-75,000
| -13% | -$1.19M |
|
4
CALL
Abbott
ABT
$182B
| $6.95M | 3.59% |
+150,000
| New | +$6.89M |
|
|
STJ
5
CALL
DELISTED
St Jude Medical
STJ
| $6.54M | 3.37% |
100,000
| – | – |
|
|
6
Insulet
PODD
$11.6B
| $5.7M | 2.94% |
170,900
+135,400
| +381% | +$4.57M |
|
|
7
Edwards Lifesciences
EW
$51.6B
| $5.7M | 2.94% |
240,000
-210,000
| -47% | -$4.71M |
|
|
8
Jazz Pharmaceuticals
JAZZ
$16.4B
| $5.62M | 2.9% |
32,500
+27,500
| +550% | +$4.72M |
|
|
ALIM
9
DELISTED
Alimera Sciences
ALIM
| $5.59M | 2.88% |
74,399
+10,872
| +17% | +$855K |
|
|
SIRO
10
CALL
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
| $5.4M | 2.79% |
+60,000
| New | +$5.42M |
|
|
SIEN
11
DELISTED
Sientra, Inc.
SIEN
| $5.24M | 2.7% |
27,310
+12,198
| +81% | +$2.08M |
|
|
12
Cigna
CI
$72.4B
| $5.05M | 2.6% |
+39,000
| New | +$4.53M |
|
13
Humana
HUM
$43.5B
| $4.9M | 2.53% |
+27,500
| New | +$4.35M |
|
14
CALL
Teleflex
TFX
$6.2B
| $4.83M | 2.49% |
+40,000
| New | +$4.63M |
|
|
15
CONMED
CNMD
$1.51B
| $4.72M | 2.43% |
+93,405
| New | +$4.58M |
|
16
Bausch Health
BHC
$2.41B
| $4.37M | 2.25% |
22,000
-1,875
| -8% | -$333K |
|
|
17
Teleflex
TFX
$6.2B
| $4.23M | 2.18% |
+35,000
| New | +$4.05M |
|
18
Smith & Nephew
SNN
$12.8B
| $4.19M | 2.16% |
122,500
+22,500
| +23% | +$796K |
|
19
CALL
Thermo Fisher Scientific
TMO
$209B
| $4.03M | 2.08% |
+30,000
| New | +$3.87M |
|
|
NUVA
20
DELISTED
NuVasive, Inc.
NUVA
| $3.67M | 1.89% |
79,800
+17,950
| +29% | +$834K |
|
21
PUT
PTC Therapeutics
PTCT
$5.77B
| $3.65M | 1.88% |
+60,000
| New | +$3.66M |
|
|
RCPT
22
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $3.54M | 1.83% |
21,500
-1,000
| -4% | -$127K |
|
|
23
CALL
Insulet
PODD
$11.6B
| $3.33M | 1.72% |
+100,000
| New | +$3.38M |
|
|
AGN
24
DELISTED
Allergan plc
AGN
| $3.24M | 1.67% |
10,875
+7,450
| +218% | +$2.12M |
|
|
25
CALL
Intuitive Surgical
ISRG
$130B
| $3.03M | 1.56% |
+54,000
| New | +$3.06M |
|
Similar funds
GMP
BCA
ONGA
RC
DOFI
SR
TC
PA
Pura Vida Investments's Q1 2015 Portfolio in Review
As of Q1 2015, Pura Vida Investments held 105 positions worth $194M, down 29% from $272M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Pura Vida Investments withdrew a net $87.1M in Q1 2015, closing 42 positions and reducing 10 holdings. Its most notable exit was Intuitive Surgical, an estimated $9.42M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 33% a quarter earlier, followed by Financials and Utilities.
Against the trend, Pura Vida Investments opened a new position in Baxter International worth $9.93M.
- Pura Vida Investments's largest Q1 2015 buy was Baxter International: 266,945 shares worth $9.93M.
- Pura Vida Investments added most to Jazz Pharmaceuticals in Q1 2015, an estimated $4.72M increase.
- Pura Vida Investments's biggest Q1 2015 reduction was Edwards Lifesciences, cutting an estimated $4.71M.
- Pura Vida Investments fully exited Intuitive Surgical in Q1 2015, selling an estimated $9.42M.
- Pura Vida Investments's ten largest holdings make up 40% of its $194M portfolio in Q1 2015.
- Pura Vida Investments opened 33 new positions and closed 42 in Q1 2015.
- Pura Vida Investments's portfolio value fell 29% quarter-over-quarter to $194M.
Based on Pura Vida Investments's 13F filing for Q1 2015, filed 14 May 2015.